- Email: [email protected]
CME introduction Osteoporosis: Strength for tomorrow
f
Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians and take responsibility for the content, quality, and scientific integrity of this CME activity. This activity was planned and produced in accordancewith the ACCME Essential Areas and Policies. Beth Israel Medical Center designatesthis continuing medical education activity for a maximum of 2 Category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit he/she actually spent in the educational activity.
Osteoporosis is a systemic skeletal diseasecharacterizedby compromised bone strength and increasedsusceptibility to fracture, and it affects more than 25 million Americans. Current research confirms the dynamic nature of bone tissue, and recent studies demonstratethat multiple factors contribute to bone quality and strength. Clinical trials in women with postmenopausalosteoporosishave shown that this is a complex disease,and multiple risk factors contribute to fractures. Specifically, the risk of hip fractures among the elderly is influenced by factors beyond low bone mass. Pharmacologic agents that improve bone strength and help prevent osteoporotic fracture provide opportunities for preventive therapy and management of this disease.
To inform health care professionals of the most recent scientific and clinical findings to better manage osteoporosis.
This activity is intended for primary care physicians, general practitioners, internal medicine physicians, and other health care professionals specializing in the care of patients with osteoporosis.
After reading this publication and taking the test, participants will be able to: 0 Understand the structural components and dynamic nature of bone, both in the normal and osteoporotic state. 0 Recognize the multiple factors that contribute to bone strength and optimal bone turnover. 0 Review and understandthe applications of therapeutic data to develop strategiesfor the treatment of osteoporosis. 0 Understand the multiple factors that inlluence the occurrence of osteoporotic hip fractures.
53
Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians and take responsibility for the content, quality, and scientific integrity of this CME activity. This activity was planned and produced in accordancewith the ACCME Essential Areas and Policies. Beth Israel Medical Center designatesthis continuing medical education activity for a maximum of 2 Category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit he/she actually spent in the educational activity.
Osteoporosis is a systemic skeletal diseasecharacterizedby compromised bone strength and increasedsusceptibility to fracture, and it affects more than 25 million Americans. Current research confirms the dynamic nature of bone tissue, and recent studies demonstratethat multiple factors contribute to bone quality and strength. Clinical trials in women with postmenopausalosteoporosishave shown that this is a complex disease,and multiple risk factors contribute to fractures. Specifically, the risk of hip fractures among the elderly is influenced by factors beyond low bone mass. Pharmacologic agents that improve bone strength and help prevent osteoporotic fracture provide opportunities for preventive therapy and management of this disease.
To inform health care professionals of the most recent scientific and clinical findings to better manage osteoporosis.
This activity is intended for primary care physicians, general practitioners, internal medicine physicians, and other health care professionals specializing in the care of patients with osteoporosis.
After reading this publication and taking the test, participants will be able to: 0 Understand the structural components and dynamic nature of bone, both in the normal and osteoporotic state. 0 Recognize the multiple factors that contribute to bone strength and optimal bone turnover. 0 Review and understandthe applications of therapeutic data to develop strategiesfor the treatment of osteoporosis. 0 Understand the multiple factors that inlluence the occurrence of osteoporotic hip fractures.
53